1. Antisense oligonucleotides: a new therapeutic principle;Uhlmann;Chem. Rev.,1990
2. Current concepts in antisense drug design;Milligan;J. Med. Chem.,1993
3. Antisense therapeutics;Agrawal;Curr. Opin. Chem. Biol.,1998
4. Disposition of the [14C]-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats;Cossum;J. Pharmacol. Exp. Ther.,1993
5. Biodistribution and metabolism of internally [3H]-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate;Sands;Mol. Pharmacol.,1994